Nevertheless, given the putative potentiating effect of α-synuclein on tau pathology (Bassil et al. 2021), and tau on α-synuclein pathology (Dasari et al. 2019), these interactions may contribute to pathological and clinical features of PLAN. The gene discussed is SNCA; the disease is neurodegeneration with brain iron accumulation 2A.